Tofacitinib Therapy for the Treatment of Alopecia Areata: Report of 11 Patients
August 2019
in “
Journal of the American Academy of Dermatology
”
TLDR Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.
The document reported on the use of Tofacitinib therapy for treating alopecia areata in a study involving 11 patients. The study aimed to evaluate the effectiveness of Tofacitinib, a Janus kinase inhibitor, in promoting hair regrowth in individuals with this autoimmune condition. The results indicated that Tofacitinib showed promise as a treatment option, with several patients experiencing significant hair regrowth. However, the small sample size of 11 patients suggested that further research with a larger cohort was necessary to confirm these findings and better understand the long-term efficacy and safety of Tofacitinib for alopecia areata.